Advertisement
Screener

PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) Material Contracts, 2017

PROTHENA CORPORATION PUBLIC LIMITED COMPANY Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2017-08-09: Form 10-Q; Exhibit 10.4; Description EXHIBIT 10.4 LETTER AGREEMENT, DATED APRIL 5, 2017.
  • 2017-08-09: Form 10-Q; Exhibit 10.3; Description EXHIBIT 10.3 ZAGO PROMOTION LETTER DATED JUNE 9, 2017.
  • 2017-08-09: Form 10-Q; Exhibit 10.2; Description EXHIBIT 10.2 NOONBERG OFFER LETTER DATED MARCH 29, 2017.
  • 2017-05-23: Form 8-K; Exhibit 10.1; Description EXHIBIT 10.1 AMENDED AND RESTATED 2012 LTIP FEB 2017.
FiledFormExhibitDescription
2017-08-0910-Q10.4EXHIBIT 10.4 LETTER AGREEMENT, DATED APRIL 5, 2017
2017-08-0910-Q10.3EXHIBIT 10.3 ZAGO PROMOTION LETTER DATED JUNE 9, 2017
2017-08-0910-Q10.2EXHIBIT 10.2 NOONBERG OFFER LETTER DATED MARCH 29, 2017
2017-05-238-K10.1EXHIBIT 10.1 AMENDED AND RESTATED 2012 LTIP FEB 2017
2017-05-0910-Q10.1EXHIBIT 10.1 AMENDED AND RESTATED INCENTIVE COMPENSATION PLAN - FEB. 2017
2017-02-2710-K10.28EXHIBIT 10.28 OFFER LETTER - CAROL KARP
2017-02-2710-K10.27EXHIBIT 10.27 DAVID MCNINCH SEPARATION AGREEMENT
2017-02-2710-K10.6EXHIBIT 10.6 COMMERCIAL SUPPLY AGREEMENT WITH RENTSCHLER

Similar stocks

Stock NameCountryMarket CapPE Ratio
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10